Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia

碩士 === 臺北醫學大學 === 保健營養學系 === 94 === Abstract This study was to compare serum vitamin B12、folate and blood-making related factors in the elderly with mild cognitive impairment (MCI) or various severity of Alzheimer’s disease (AD). MCI or AD was diagnosed by doctors. CDR (clinical dementia rating) was...

Full description

Bibliographic Details
Main Authors: YANG HUI-MEI, 楊惠玫
Other Authors: Shu-Jan Lan, Ph.D.
Format: Others
Language:zh-TW
Published: 2006
Online Access:http://ndltd.ncl.edu.tw/handle/91629535223439688154
id ndltd-TW-094TMC00217024
record_format oai_dc
spelling ndltd-TW-094TMC002170242015-12-18T04:03:59Z http://ndltd.ncl.edu.tw/handle/91629535223439688154 Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia 輕度智能受損與阿茲海默症老人的血清維生素B12、葉酸與造血相關指標 YANG HUI-MEI 楊惠玫 碩士 臺北醫學大學 保健營養學系 94 Abstract This study was to compare serum vitamin B12、folate and blood-making related factors in the elderly with mild cognitive impairment (MCI) or various severity of Alzheimer’s disease (AD). MCI or AD was diagnosed by doctors. CDR (clinical dementia rating) was used to evaluate cognitive function. CDR scores of 0.5 were classified as MCI;1 as mild AD;2 as moderate AD and 3 as severe AD. All data required for the study were extracted from medical charts. A total of 218 subjects involved: 51 were MCI, 68 were mild AD, 50 were moderate AD and 49 were severe AD. MMSE scores in MCI, mild, moderate and severe AD groups were 27.1 ± 2.3、19.8 ± 4.7、16.4 ± 4.2 and 4.7 ± 2.7points, respectively. Serum vitamin B12 were 724.7 ± 410.7、656.1 ± 452.8、491.2 ± 215.1 and 326.6 ± 130.7 pg / mL. MCI or mild AD group had higher serum vitamin B12 than moderate and severe AD groups. Serum folate in four groups were 14.1 ± 5.1、14.8 ± 6.5、13.0 ± 4.8 and 9.7 ± 3.9 ng / mL. MCI or mild AD group had higher serum folate than severe AD group. Four groups had anemia according to Hb (Hct):MCI 43.1(33.3) %、mild AD 41.2(42.6) %、moderate AD 50.0(50.0) % and severe AD group 36.7 %(24.5 %). The prevalence of high MCV in four groups:7.8、20.6、14.0 and 8.2 %. Hypoalbuminemia occurred as 5.9、5.9、6.0 and 14.3 % in four groups. Poor liver function as indicated by high sGPT level was uncommon, only 2.0 ~ 2.9 % in four groups of subjects. In conclusion, serum vitamin B12 and folate decline as AD deteriorates. Anemia is common in the elderly with MIC or various degree of AD as indicated by blood related markers Hb、Hct or MCV and Hb is the most sensitive markers of anemia. Hypoalbuminemia occurs in 14.3 % of the elderly with severe AD, the highest prevalence among four groups. Keywords : Alzheimer’s disease, mild cognitive impairment, elderly, vitamin B12, folate Shu-Jan Lan, Ph.D. 蘭淑貞 2006 學位論文 ; thesis 90 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 臺北醫學大學 === 保健營養學系 === 94 === Abstract This study was to compare serum vitamin B12、folate and blood-making related factors in the elderly with mild cognitive impairment (MCI) or various severity of Alzheimer’s disease (AD). MCI or AD was diagnosed by doctors. CDR (clinical dementia rating) was used to evaluate cognitive function. CDR scores of 0.5 were classified as MCI;1 as mild AD;2 as moderate AD and 3 as severe AD. All data required for the study were extracted from medical charts. A total of 218 subjects involved: 51 were MCI, 68 were mild AD, 50 were moderate AD and 49 were severe AD. MMSE scores in MCI, mild, moderate and severe AD groups were 27.1 ± 2.3、19.8 ± 4.7、16.4 ± 4.2 and 4.7 ± 2.7points, respectively. Serum vitamin B12 were 724.7 ± 410.7、656.1 ± 452.8、491.2 ± 215.1 and 326.6 ± 130.7 pg / mL. MCI or mild AD group had higher serum vitamin B12 than moderate and severe AD groups. Serum folate in four groups were 14.1 ± 5.1、14.8 ± 6.5、13.0 ± 4.8 and 9.7 ± 3.9 ng / mL. MCI or mild AD group had higher serum folate than severe AD group. Four groups had anemia according to Hb (Hct):MCI 43.1(33.3) %、mild AD 41.2(42.6) %、moderate AD 50.0(50.0) % and severe AD group 36.7 %(24.5 %). The prevalence of high MCV in four groups:7.8、20.6、14.0 and 8.2 %. Hypoalbuminemia occurred as 5.9、5.9、6.0 and 14.3 % in four groups. Poor liver function as indicated by high sGPT level was uncommon, only 2.0 ~ 2.9 % in four groups of subjects. In conclusion, serum vitamin B12 and folate decline as AD deteriorates. Anemia is common in the elderly with MIC or various degree of AD as indicated by blood related markers Hb、Hct or MCV and Hb is the most sensitive markers of anemia. Hypoalbuminemia occurs in 14.3 % of the elderly with severe AD, the highest prevalence among four groups. Keywords : Alzheimer’s disease, mild cognitive impairment, elderly, vitamin B12, folate
author2 Shu-Jan Lan, Ph.D.
author_facet Shu-Jan Lan, Ph.D.
YANG HUI-MEI
楊惠玫
author YANG HUI-MEI
楊惠玫
spellingShingle YANG HUI-MEI
楊惠玫
Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia
author_sort YANG HUI-MEI
title Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia
title_short Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia
title_full Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia
title_fullStr Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia
title_full_unstemmed Serum vitamin B12、folate and blood relative markers in the elderly patients with mild cognitive impairment and Alzheimer’s dementia
title_sort serum vitamin b12、folate and blood relative markers in the elderly patients with mild cognitive impairment and alzheimer’s dementia
publishDate 2006
url http://ndltd.ncl.edu.tw/handle/91629535223439688154
work_keys_str_mv AT yanghuimei serumvitaminb12folateandbloodrelativemarkersintheelderlypatientswithmildcognitiveimpairmentandalzheimersdementia
AT yánghuìméi serumvitaminb12folateandbloodrelativemarkersintheelderlypatientswithmildcognitiveimpairmentandalzheimersdementia
AT yanghuimei qīngdùzhìnéngshòusǔnyǔāzīhǎimòzhènglǎoréndexuèqīngwéishēngsùb12yèsuānyǔzàoxuèxiāngguānzhǐbiāo
AT yánghuìméi qīngdùzhìnéngshòusǔnyǔāzīhǎimòzhènglǎoréndexuèqīngwéishēngsùb12yèsuānyǔzàoxuèxiāngguānzhǐbiāo
_version_ 1718154125251706880